Could Vertex Pharmaceuticals Stock Help You Become a Millionaire?
Biotech company Vertex Pharmaceuticals (NASDAQ: VRTX) has made for a solid investment over the past decade, more than quadrupling in value during that period. The stock generated fantastic returns for investors and this year it's also up around 20% as there's still ample bullishness around the business. The company is a leader in cystic fibrosis treatments with an eye for more growth and diversification in the long run.
Does Vertex have the potential to be a millionaire-making investment going forward?
The challenge for Vertex Pharmaceuticals will be to keep its growth rate strong. For the quarter ending June 30, the company's sales totaled $2.5 billion and were up 14% year over year. That revenue comes mainly from cystic fibrosis products, specifically Trikafta/Kaftrio, which generated over $2.2 billion.
Source Fool.com
Vertex Pharmaceuticals Inc. Stock
With 60 Buy predictions and 2 Sell predictions Vertex Pharmaceuticals Inc. is one of the favorites of our community.
As a result the target price of 459 € shows a slightly positive potential of 4.77% compared to the current price of 438.1 € for Vertex Pharmaceuticals Inc..
